SCHEMBL9660833

SCHEMBL9660833

CN(N)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27946578 0.73
SCHEMBL20462320 0.70
SCHEMBL2154246 0.70
SCHEMBL124148 0.67
Hydrochloric Acid SCHEMBL28024752 0.67
SCHEMBL7153696 0.67
SCHEMBL10054281 0.65
SCHEMBL1682929 0.65
SCHEMBL28081962 0.65
SCHEMBL48575 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114450281-B Inhibitor compounds 辛塞拉治疗私人有限公司 2024-08-16 CN disclosed
US-20230203408-A1 CLEANING LIQUID AND METHOD FOR CLEANING SUBSTRATE TOKYO OHKA KOGYO CO., LTD. (JP) 2023-06-29 US disclosed
EP-3507275-B1 CXCR3 RECEPTOR AGONISTS RECEPTOS LLC (US) 2023-04-26 EP disclosed
US-20230041563-A1 N-(1,3,4-OXADIAZOL-2-YL)ARYLCARBOXAMIDES OR SALTS THEREOF, PREPARATION METHODS, HERBICIDAL COMPOSITIONS AND USES THEREOF QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD. (CN) 2023-02-09 US disclosed
US-20230022904-A1 Broad Orthogonal Distribution Polyethylenes for Films EXXONMOBIL CHEMICAL COMPANY LAW TECH (US) 2023-01-26 US disclosed
US-20230021760-A1 Biaxially Oriented Polyethylene Films and Process for Production Thereof EXXONMOBIL CHEMICAL PATENTS INC (US) 2023-01-26 US disclosed
CN-114450281-A Inhibitor compounds 辛塞拉治疗私人有限公司 2022-05-06 CN disclosed
WO-2022002243-A1 IMIDAZOPYRIMIDINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 江苏恒瑞医药股份有限公司 2022-01-06 WO disclosed
US-10391070-B2 Compositions and methods for treating neurological diseases or injury MUSC FOUNDATION FOR RESEARCH DEVELOPMENT (US) 2019-08-27 US disclosed
EP-1922389-B1 ABSORBENT COMPOSITION CONTAINING MOLECULES WITH A HINDERED AMINE AND A METAL SULFONATE STRUCTURE FOR ACID GAS SCRUBBING PROCESS EXXONMOBIL RES & ENG CO (US) 2019-02-20 EP disclosed
US-20180185306-A1 COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISEASES OR INJURY MUSC FOUNDATION FOR RESEARCH DEVELOPMENT (US) 2018-07-05 US disclosed
EP-2725065-B1 INJECTION-MOLDED BODY MITSUBISHI GAS CHEMICAL CO (JP) 2018-06-06 EP disclosed
US-20180072745-A1 IRE-1alpha INHIBITORS FOSUN ORINOVE PHARMATECH, INC. (CN) 2018-03-15 US disclosed
US-20170080097-A1 DENDRIMERIC PLATFORM FOR CONTROLLED RELEASE OF DRUGS ARIEL-UNIVERSITY RESEARCH AND DEVELOPMENT COMPANY LTD. (IL) 2017-03-23 US disclosed
US-9598374-B2 Arginine methyltransferase inhibitors and uses thereof Epizyme, Inc. (US) 2017-03-21 US disclosed
WO-2012058203-A1 DIAZENIUMDIOLATE HETEROCYCLIC DERIVATIVES MERCK SHARP & DOHME CORP. (US) 2012-05-03 WO disclosed
US-8048912-B2 Benzopyran derivatives having inhibitory activities against liver fibrosis and cirrhosis and their pharmaceutical uses SK CHEMICALS CO., LTD. (KR) 2011-11-01 US disclosed
US-20090118302-A1 Novel Benzopyran Derivatives Having Inhibitory Activities Against Liver Fibrosis and Cirrhosis and Their Pharmaceutical Uses KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2009-05-07 US disclosed
EP-0497122-A1 Substituted 3-aminosydnonimines, process for their preparation and their use CASSELLA Aktiengesellschaft (DE) 1992-08-05 EP disclosed